BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, March 21, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 30, 2022
View Archived Issues
ADAM10 may be a promising therapeutic target for AML
Read More
Sunshine Lake Pharma patents new GCGR and/or GLP-1 receptor agonists
Read More
Eubulus Biotherapeutics discloses new GPX4 inhibitors
Read More
Roche presents new EGFR mutant inhibitors
Read More
Reistone Biopharma divulges new CatC inhibitors
Read More
Palacky University patents new terpenoid derivatives
Read More
Novel mouse models of BrafV600E-driven thyroid tumors
Read More
Alaunos and NCI extend CRADA to assess use of Sleeping Beauty technology for TCR T-cell therapy
Read More
Ascentage receives IND clearance for first-in-human study of EED inhibitor APG-5918
Read More
HNSCC treatment should focus on targeting TSPAN1
Read More
Generian and Mitobridge collaborate to discover and develop small molecules for undruggable targets
Read More
Tumors might be nudged to more treatable state
Read More
IAMA reports responses with selective NKCC1 inhibitors in animal models of Down syndrome and autism
Read More
Anti-VISTA monoclonal antibody KVA-12.1 produces antitumor responses in vivo
Read More
